Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | American Heart Journal |
| Vol/bind | 157 |
| Udgave nummer | 2 |
| Sider (fra-til) | 384-90 |
| Antal sider | 7 |
| ISSN | 0002-8703 |
| DOI | |
| Status | Udgivet - 2009 |
Bibliografisk note
Keywords: Adiposity; Adult; Aged; Alcohol Drinking; Case-Control Studies; Coronary Disease; Female; Genotype; Health Behavior; Humans; Lipids; Lipoprotein Lipase; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; SmokingAdgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. / Jensen, Majken K; Rimm, Eric B; Rader, Daniel; Schmidt, Erik B; Sørensen, Thorkild I A; Vogel, Ulla; Overvad, Kim; Mukamal, Kenneth J.
I: American Heart Journal, Bind 157, Nr. 2, 2009, s. 384-90.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies
AU - Jensen, Majken K
AU - Rimm, Eric B
AU - Rader, Daniel
AU - Schmidt, Erik B
AU - Sørensen, Thorkild I A
AU - Vogel, Ulla
AU - Overvad, Kim
AU - Mukamal, Kenneth J
N1 - Keywords: Adiposity; Adult; Aged; Alcohol Drinking; Case-Control Studies; Coronary Disease; Female; Genotype; Health Behavior; Humans; Lipids; Lipoprotein Lipase; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Smoking
PY - 2009
Y1 - 2009
N2 - BACKGROUND: Lipoprotein lipase (LPL) has a prominent role in the metabolism of triglycerides (TGs) and high-density lipoprotein cholesterol (HDL-C) and is a potential interesting target for the development of antiatherogenic treatment. To provide deeper insight into the role of natural variation in this gene, we investigated the association between the LPL S447X variant with lipids and risk of coronary heart disease (CHD) in 3 independent, prospective studies. METHODS: The S447X variant was genotyped in case-control studies of incident CHD nested within the Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), and the Danish Diet, Cancer and Health (DCH) study, totaling 245, 258, and 962 cases, respectively. RESULTS: S447X carriers tended to have lower TG and higher HDL-C concentrations than noncarriers. The S447X variant was associated with a lower risk of CHD in the NHS; the association was weaker in the HPFS and not statistically significant in the DCH women and men. The pooled relative risk per minor allele was 0.74 (0.56-1.00). There was a suggestion that the associations of the S447X variant with plasma lipids and CHD risk were more pronounced in obese individuals in the NHS study, but this finding was not consistent across the studies. CONCLUSIONS: The LPL S447X variant tended to be associated with lower TG and higher HDL-C levels, and lower risk of CHD in all 3 cohorts. Lipoprotein lipase is an attractive target for clinical intervention, but studies are needed to clarify whether greater benefit from this variant may be conferred in some subgroups.
AB - BACKGROUND: Lipoprotein lipase (LPL) has a prominent role in the metabolism of triglycerides (TGs) and high-density lipoprotein cholesterol (HDL-C) and is a potential interesting target for the development of antiatherogenic treatment. To provide deeper insight into the role of natural variation in this gene, we investigated the association between the LPL S447X variant with lipids and risk of coronary heart disease (CHD) in 3 independent, prospective studies. METHODS: The S447X variant was genotyped in case-control studies of incident CHD nested within the Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), and the Danish Diet, Cancer and Health (DCH) study, totaling 245, 258, and 962 cases, respectively. RESULTS: S447X carriers tended to have lower TG and higher HDL-C concentrations than noncarriers. The S447X variant was associated with a lower risk of CHD in the NHS; the association was weaker in the HPFS and not statistically significant in the DCH women and men. The pooled relative risk per minor allele was 0.74 (0.56-1.00). There was a suggestion that the associations of the S447X variant with plasma lipids and CHD risk were more pronounced in obese individuals in the NHS study, but this finding was not consistent across the studies. CONCLUSIONS: The LPL S447X variant tended to be associated with lower TG and higher HDL-C levels, and lower risk of CHD in all 3 cohorts. Lipoprotein lipase is an attractive target for clinical intervention, but studies are needed to clarify whether greater benefit from this variant may be conferred in some subgroups.
U2 - 10.1016/j.ahj.2008.10.008
DO - 10.1016/j.ahj.2008.10.008
M3 - Journal article
C2 - 19185650
VL - 157
SP - 384
EP - 390
JO - American Heart Journal
JF - American Heart Journal
SN - 0002-8703
IS - 2
ER -